Masonic Cancer Center, University Of Minnesota

This study tested a new three-drug combination (PTCy, sirolimus, and VIC-1911) to prevent two major problems after a stem cell transplant: graft-versus-host disease (GVHD) and cancer relapse. It involved 16 adults with blood cancers like leukemia and lymphoma who received a high-…

This early-stage study tested a new injectable drug called HCW9218 in 18 people with advanced solid tumors that had stopped responding to at least two prior treatments. The main goal was to find the highest safe dose. The drug is designed to work like a double agent: it aims to b…

This study tested a radioactive drug called 131I-MIBG as a treatment for people with advanced neuroblastoma (a childhood nerve cancer) or metastatic pheochromocytoma (a rare adrenal gland tumor) that had stopped responding to standard treatments. The main goal was to provide acce…

This study tested whether a daily drink made from freeze-dried watercress could help the body remove harmful environmental chemicals linked to cancer. It involved 300 healthy adults, who took either the watercress drink or a placebo for two weeks. The research focused on people w…

This study tested whether physical therapy helps with shoulder pain, stiffness, and swelling that can occur after breast cancer surgery. Researchers compared women who received physical therapy to those who didn't, measuring shoulder movement, pain levels, and arm function. The g…

This study aimed to understand if the amount of sugar in cigarette tobacco affects how satisfying and addictive the cigarettes are. Thirty adult smokers attended clinic visits to smoke cigarettes with different sugar levels and filled out questionnaires about their experience. Th…

This was a small pilot study to see if researchers could run a smoking study completely remotely using video calls and mail-in kits. It tested whether cigarettes with less air flow in the filter change how much people smoke or the levels of harmful chemicals in their body. The ma…